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Abstract.  Cleavage and release of membrane protein 
ectodomains, a regulated process that affects many cell 
surface proteins,  remains largely uncharacterized.  To 
investigate whether cell surface proteins are cleaved 
through a  shared mechanism or through multiple inde- 
pendent mechanisms,  we mutagenized Chinese ham- 
ster ovary (CHO) cells and selected clones that were 
unable to cleave membrane-anchored transforming 
growth factor o~ (TGF-a).  The defect in TGF-a cleav- 
age in these clones is most apparent upon cell treat- 
ment with the protein kinase C  (PKC) activator PMA, 
which stimulates TGF-ct  cleavage in wild-type cells. 
The mutant clones do not have defects in TFG-ct ex- 
pression, transport to the cell surface or turnover. 
Concomitant with the loss of TGF-ot cleavage, these 
clones have lost the ability to cleave many structurally 
unrelated membrane proteins in response to PMA. 
These proteins include ~-amyloid precursor protein 
(/3-APP),  whose cleavage into a secreted form avoids 
conversion into the amyloidogenic peptide A/~, and a 
group of cell surface proteins whose release into the 
medium is stimulated by PMA in wild type CHO cells 
but not in mutants.  The mutations prevent cleavage by 
PKC-dependent as well as PKC-independent mecha- 
nisms,  and thus affect an essential component that 
functions downstream of these various signaling mech- 
anisms.  We propose that regulated cleavage and secre- 
tion of membrane protein ectodomains is mediated by 
a  common system whose components respond to mul- 
tiple activators and act on susceptible proteins of di- 
verse structure and function. 
large  group of membrane proteins undergo cleavage 
with release of their ectodomain into the extracel- 
ular medium (Ehlers and Riordan,  1991). This group 
includes membrane-anchored growth factors (Massagu6 and 
Pandiella,  1993),  growth  factor  receptors,  cell  adhesion 
molecules, ectoenzymes and molecules of unknown function 
such as the ~-amyloid precursor protein (Ehlers  and Rior- 
dan,  1991; Massagu6  and  Pandiella,  1993).  Membrane- 
anchored growth factors and ectoenzymes provide localized 
concentrations of these activities,  and their cleavage yields 
soluble forms that can diffuse and act at a distance from the 
site of production (Ehlers and Riordan, 1991; Massagu6 and 
Pandiella,  1993).  The membrane-anchored  forms of these 
proteins may be biologically more effective than the soluble 
forms,  as in the case of kit ligand/stem  cell growth factor 
whose soluble form  cannot  substitute  for its  membrane- 
anchored  form  in  critical  aspects of mouse development 
(Flanagan et al., 1991). Cleavage switches the role of growth 
factor receptors and cell adhesion  molecules by converting 
them into soluble antagonists  of the factors they bind (Fer- 
mindez-Botran,  1991; Gordon, 1991). Cleavage of~-amyloid 
precursor  protein  (/~-APP)  1 releases a  large  soluble form 
(APPs)  that  escapes the  intracellular  degradative  process 
that yields AB (Esch et al., 1990; Sisodia et al., 1990; Golde 
et al., 1992; Haass and Selkoe,  1993). Deposits of insoluble 
A/3 are invariably associated with Alzheimer's  disease,  sug- 
gesting that defects in ~-APP release may play a role in the 
pathogenesis of this disease (Haass and Selkoe, 1993). Thus, 
cleavage  and  secretion  of membrane protein ectodomains 
fulfills different biological  roles depending  on the protein, 
and alterations  in this process may lead to disease. 
Cleavage  of membrane  protein  ectodomains  is  often a 
regulated  process. The extracellular  domains  of proTGF-ot 
(Pandiella  and Massagu6,  1991a), kit ligand (Huang et al., 
1992), colony-stimulating  factor 1 (CSF-1) (Stein and Ret- 
tenmier,  1991), CSF-1 receptor (Downing et al.,  1989), tu- 
mor necrosis factor ct (TNF-ot) receptors (Porteu and Na- 
than,  1990; Porteu et al., 1991), IL-6 receptor (Serra-Pages 
et al.,  1994),  LAR transmembrane protein tyrosine phos- 
phatase (Miillberg et al., 1992), ~APP protein (Buxbaum et 
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et al., 1989; Kahn et al., 1994), and angiotensin-converting 
enzyme (Ramchandrarn et al.,  1994) are released at a slow 
rate in resting cells but are cleaved minutes after adding cer- 
tain agonists including protein kinase C activators, calcium 
ionophores,  and  serum  factors (Pandiella and Massagu6, 
1991b; Buxbaum et al.,  1994). 
Despite the biological importance of this process, the cel- 
lular components involved in it have eluded identification. 
Indirect evidence suggests that membrane protein ectodo- 
main cleavage is catalyzed by membrane-associated proteo- 
lytic activities that act at the cell surface (Sisodia,  1992; 
Bosenberg et al., 1993). These enzymes preferentially attack 
peptide bonds located at a certain distance from the trans- 
membrane region, the amino acid sequence flanking these 
sites being of secondary importance (Sisodia, 1992). A wide 
variety of primary sequences can be cleaved by this system, 
and extensive mutation of the regions proximal to the cleav- 
age site in proTGF-c~ (Wong et al.,  1989;  Pandiella et al., 
1992), TNF-c~ (Perez et al., 1990), ~APP (Sahasrabudhe et 
al.,  1992;  Sisodia,  1992),  and IL-6 receptor (Mtillberg et 
al.,  1994) is necessary to prevent their cleavage. 
One basic question for which there has been no answer is 
whether cleavage of this extremely diverse group of mem- 
brane proteins occurs through a shared mechanism or multi- 
ple independent mechanisms. To investigate this question, 
and to provide a genetic system for the study of this process, 
we mutagenized cell cultures and selected cell clones that 
were unable to cleave membrane TGF-c~. We then asked if 
these clones were also defective in cleavage  of other un- 
related membrane proteins. 
Materials and Methods 
Construction of  HA-tagged proTGFc~ 
The pro-HA/TGF-ct construct was generated by inserting the HA1 epitope 
of influenza virus  hemagglutinin (Meloche et al.,  1992) between amino- 
acids 42 and 43 of rat proTGF-ct (Lee et al., 1985a) using the polymerase 
chain reaction (PCR). The following oligonucleotides were used: 5'-GC~C- 
TCTAGAAGAGCGCGGTCrCd2TGCA-3' containing nucleotides -36 to -19 
of the rat proTGF-c~ eDNA preceded by a XbaI site (underlined),  5'-GCTT- 
GGATCCTCAGACCACTGTCTCAGAGTGGCAGCA-3' containing nucleo- 
tides 455 to 480 of  the rat proTGF-c~  followed by a BamHI site (underlined), 
5'-AGC,  ATAATCAGGAACATCATAGTGAGACAC  CACTGCAGC  -3  ',  con- 
taining  nueleotides  109 to  126 of proTGF-c~ followed by 21  nuclcotides 
encoding the last seven aminoacids of the HA epitopo (underlined)  and 
5'-  GTTC TTGATTA'IGC  TAC,-CC  TCTTC.AACAAG  "[C.d2C  CAGAT-  3  '  con- 
taining nucleotides 127 to 144 of proTGF-c~ preceded by 21 nucleotides en- 
coding the first seven aminoacids of  the HA epitope. The product of  the final 
PCR reaction was subeloned into the pVAO  expression vector (P~bo et al., 
1986) and confirmed by sequencing. 
Cell Transfection and Mutagenesis 
CHO cells were cultured in monolayers in DME supplemented with 10% 
fetal bovine serum (GIBCO BRL, Gaithersburg, MD). The pVAO vector 
containing the HA tagged proTGF-c~ was cotransfected with the selectable 
plasmid pCDneo at a DNA ratio  1:25 into CHO cells using the calcium 
phosphate precipitate  method.  Stable transfectants were selected in 500 
/~g/mi Geneticin  (GIBCO) and  subcloned.  One  clone  expressing  pro- 
HA/TGF-ct at high levels was mutagonized with 0.35 p,l/ml ethyl methane 
sulphonate under conditions that killed '~40% of the cells. The ceils were 
allowed to recover for five days. Wild-type and mutant CHO ceils were 
transfected with the pCEP-4 plasmid (Invitrogene, San Diego, CA) contain- 
ing the eDNA encoding the human/~-APP  695 using the calcium phosphate 
precipitate method. Transfectants were selected in 600/~g/rrd hygromicin 
(Calbiochem Corp., La Jolla, CA) and subcloned. 
Fluorescence  Analysis 
Cells  were  incubated  with  10  /~g/rnl of anti-HA  monoclonal  antibody 
(12CA5; Babco, Richmond, CA) in PBS containing 5% BSA for 30 rain at 
room temperature, then incubated for 30 rain with or without 1 ~M PMA 
(Sigma Chemical Co., St. Louis, MO) in complete medium at 37"C, and 
stained for 30 rain at 4°C with FITC-conjugated anti-mouse IgG (Becton- 
Dickinson) in PBS containing 5 % BSA. Flow cytometry was done on a 
FACscan  using  FACscan Research  software  (Becton  Dickinson  Im- 
munocytometry  Sys.,  Mountain View, CA).  Cell sorting was done on a 
FACStar-Plus system  (Becton  Dickinson).  Photomicrographs  were  ob- 
tained using cells immunostained and treated as above. 
Metabolic Labeling, Immunoprecipitation, 
and Biotinylation of Cell Surface Proteins 
For immunoprecipitation of TGF-c~ localized at the cell surface,  106 ex- 
ponentially growing cells wen: labeled for 10 or 20 rain with 250/~Ci/ml 
of [35S]cysteine  (DuPont-New England Nuclear, Boston, MA) in cysteine- 
free medium, at 37°C. The label was chased in complete medium for differ- 
em times,  and cells were then shifted to 4°C and incubated for 30 rain with 
10 #g/ml of anti-HA antibody in PBS containing 5% BSA at 4°C. After in- 
cubation with anti-HA antibody, cells were shifted to 37°C, incubated in 
complete medium with or without activators of TGF-a cleavage for various 
times as indicated, and then lysed in lysis buffer (1% NP-40, 5 mM EDTA, 
and 5 mg/ml of HA peptide). Insoluble material was removed from cell 13'- 
sates by centrifngation. The cell lysates and aliquots from the media were 
incubated with protein A for 40 rain at 4°C, and immune complexes washed 
three times with a solution containing 0.1% Triton X-100 and 0.1% SDS. 
Samples from cell lysates were resolved in 14% polyacrylamide gels, and 
samples from media were resolved in 16% polyacrylamide gels. Where in- 
dicated,  cell  lysates Were immunoprecipitated  with  antibodies  directed 
against the cytoplasmic tail of TGF-a  (Bosenberg et al.,  1992). 
For fl-APP immunoprecipitatinn, cells were labeled with 250 #Ci/ml of 
[35S]methionine (DuPont-New England Nuclear)  for 20  min in methio- 
nine-fre~ medium, and chased in complete medium for various times. Cells 
were then lysed in PBS containing 1% NP-40, 0.5% sodium deoxycholate, 
0.1% SDS, and 5 mM EIYrA, and insoluble material was removed by cen- 
trifngation. Cell lysates were immunoprecipitated with 3 izl of polyclonal 
antiserum  against  the  cytoplasmic  domain  of B-APP (Buxbaum et al., 
1990).  Media  supernatants  were  immunoprecipitated  with  5  ~g/ml  of 
monoclonal antibody against the extracellular domain of B-APP (22Cll; 
Boehringer Mannbeim Corp., Indianapolis, IN). Immune complexes were 
washed three times with a solution containing 0.1% Triton X-100 and 0.1% 
SDS. Samples were electrophoresed on SDS-PAGE  gels of the appropriate 
density (either 6 or 17% polyacrylamide) to resolve proteins of interest. 
For biotinylation of cell surface B-APP, cells  were labeled with 500 
~Ci/ml  of [35S]methionine and  500  ~Ci/ml  of [35S]cysteine for 2  h  in 
methionine-  and  cysteine-free medium,  chased  for 45  rain in complete 
medium and washed three times with Krebs Ringer Hepes buffer at 4°C. 
Cells were then incubated in the same buffer containing 1 mg/ml of sulfo- 
NHS-LC-Biotin (Pierce Chem. Co., Rockford, IL) for 30 min at 4°C. Ex- 
cess biotinylating reagent was quenched by washing with  10 mM glycine 
in Krebs Ringer Hepes buffer. Metabolically labeled biotinylated cells were 
shifted to 37°C and incubated for 15 rain in DME with or without 1 ~m 
PMA, 1 gM A23187 or 10 % fetal bovine serum. Cell lysates were immuno- 
precipitated with antibodies against the fl-APP cytoplasmic tail as above. 
Immunoprecipitated/~-APP was eluted from washed protein A beads with 
100 mM glycina (pH 2.5) and 10/xM competing B-APP COOH-terminal 
peptide (corresponding to aminoacids 636-694  of human/~/-App69s). Su- 
pernatants  were removed, neutralized,  and incubated with streptavidin- 
Sepharose beads (Pierce) for 30 min at 4°C. The streptavidin agarose beads 
were washed with 0.1% Triton 3[-100 and 0.1% SDS, and analyzed on 6% 
polyacrylamide gels. 
For cell surface biotinylation of endogenous membrane proteins, ceils 
were  labeled  with  250  ttCi/ml  of [3SS]methionine and  250  ttCi/ml  of 
[35S]cysteine for 2 h in methionine- and cysteine-free medium, chased for 
30 min in complete medium, shifted to 4°C and incubated with sulfo-NHS- 
LC-Biotin as described above. After biotinylation, cells were incubated for 
15 min at 37°C in complete medium with or without PMA. Media samples 
were incubated with streptavidin agarose beads, and the beads washed with 
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acrylamide gels. 
Results 
Isolation of CHO Cell Mutants Defective 
in TGF-ot Cleavage 
To generate cell mutants defective in proTGF-ot cleavage, we 
first transfected CHO cells with the construct pro-HA/TGF-ot 
that encodes the rat TGF-, precursor (Lee et al.,  1985b) 
tagged with an influenza virus hemagglutinin epitope (HA) 
(Meloche et al.,  1992).  This tag was used to facilitate im- 
munostaining  of intact  cells  expressing  pro'l'GF-e~  on  the 
surface,  and was inserted immediately downstream of the 
NI-I2-terminal "I'GF-o~  cleavage site (Fig.  1 A). Immunofluo- 
rescence analysis of stably transfected CHO cells  stained 
with anti-HA antibody revealed proTGF-ot expression at the 
cell surface (Fig. 1 D, top left) that was not detected in mock 
transfectants (not shown). As determined by flow cytometry, 
addition of the PKC activator PMA markedly reduced the 
HA immunofluorescence in these transfectants  (Fig.  1 B) 
and induced the release of HA/TGF-e~ immune complexes 
into the media (see below). These observations were con- 
firmed by immunofluorescence microscopy (Fig.  1 D, bot- 
tom left), and were consistent with the known ability of PMA 
to  induce  proTGF-ot  cleavage  (Pandiella  and  Massagu6, 
1991a). 
Figure  1.  Isolation  of CHO 
cell mutants defective in TGFot 
cleavage.  (A)  Schematic  of 
the pro-HA/TGF-~ construct 
showing the  signal  sequence 
(black box), the  TGF-~ do- 
main (shaded box), the trans- 
membrane  domain  (hatched 
box),  the  HA  epitope  se- 
quence  and  its  site  of inser- 
tion.  Numbers  denote  amino 
acid  positions.  (B)  Flow 
cytometry  analysis  of  CHO 
cells  stably  transfected  with 
pro-HA/TGF-c~,  immuno- 
stained with anti-HA and in- 
cubated  with  or  without 
PMA. (C) Flow cytometry of 
the  mutagenized  transfectant 
cell population after the third 
and fourth cycles of selection 
for cells  that  remained  HA  + 
after  treatment  with  PMA. 
(D) Photomicrographs of pro- 
HA/TGF-ot  CHO  transfec- 
tants  (Wi/d type) and  one of 
the TGF-a cleavage-deficient 
clones  (Mutant)  immuno- 
stained with HA antibody af- 
ter treatment with or without 
PMA. 
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cleavage, one of the pro-HA/TGF-ot transfectant clones was 
mutagenized with ethyl methane sulphonate and the cells al- 
lowed to recover for five days.  The mutagenized population 
was immunostained with HA antibody, treated with PMA, 
and the 1% brightest cells in this population were selected 
in a cell sorter. The sorted population was expanded and the 
selection cycle repeated  four  times.  After the  first three 
rounds of cell sorting,  no cells could be detected that re- 
mained bright upon PMA addition (Fig. 1 D). However, after 
the fourth round of selection, 38 % of the cell population re- 
tained high HA immunofluorescence upon treatment with 
PMA, as determined by flow cytometry of an aliquot from 
this population (Fig.  1 C). Of 10 clones randomly isolated 
from  this  population,  four  showed  complete  absence  of 
PMA-induced  proTGF-ct cleavage,  as  determined  by  im- 
munofluorescence (Fig.  1 D) and flow cytometry (not shown). 
Each of these clones maintained this phenotype for at least 
three months in culture (~160 cell doublings) after which 
three of the clones progressively reverted to the wild-type 
phenotype presumably owing to a growth advantage in the 
spontaneous revertants. The mutant phenotype of one of the 
clones has remained unchanged after 12 mo of culture. 
TGF-t~ Biosynthesis,  Transport, and Turnover 
in Wild-type and Mutant CHO Cells 
To determine whether the phenotype of these mutants was 
due to a  specific defect in proTGF-ct cleavage or to some 
general defect in proTGF-c~ biosynthesis or transport to the 
cell surface, we compared the rates of proTGF-ct synthesis, 
transport to the cell surface and turnover in parental and mu- 
tant CHO cells. TGF-o~ is synthesized as a 18-kD precursor 
that is heterogeneously glycosllated yielding forms of 20-22 
kD.  These forms are then transported to the cell surface 
where rapid cleavage of the NH2-terminal pro-region leaves 
a  17-kD  membrane-anchored  form  (Pandiella  and  Mas- 
sagu6,  1991a; Bosenberg et al., 1992). In the absence of  acti- 
vators, TGF-tx slowly turns over without significant release 
of mature growth factor to the media (Pandiella and Mas- 
sagu6,  1991a;  Bosenberg et al.,  1992). TGF-a products of 
molecular size and order of appearance consistent with this 
process appeared at  similar  rates  in  parental  and  mutant 
CHO  cells.  Metabolic  pulse-chase  labeling  followed  by 
precipitation of cell lysates with antibodies directed against 
the proTGF-o~  cytoplasmic region (Fig. 2, whole cell) showed 
the appearance of a  18-kD immunoreactive species that was 
chased  into 20-22  kD  forms and,  soon thereafter,  into  a 
17-kD form. 
To determine the rate of appearance of pro-HA/TGF-ot at 
the cell surface, the same set of metabolically labeled cells 
was incubated with anti-HA antibody, washed and lysed. Im- 
mune complexes recovered from these lysates with protein 
A-agarose  showed  that  the  newly  synthesized 20--22  kD 
form appeared on the cell surface at the same rate in both 
the wild-type and mutant cells, and was rapidly converted 
into the 17-kD form in both cell lines (Fig. 2, cell surface). 
Loss of  cell surface proTGF-o~  was clear after 90 min of  chase 
in both wild-type and mutant cells (Fig. 2). This loss is at- 
tributable to general membrane protein turnover. In the par- 
ticular experiment shown here, the wild-type cells exhibited 
a somewhat faster rate of TGF-oL  loss, likely due to a basal 
level of proTGF-ot cleaving activity. This possibility is sup- 
ported by the accumulation, after 60 min, of a  15-kD im- 
munoreactive product (see Fig. 3, whole wild type cell) that 
corresponds to proTGF-ot transmembrane/cytosolic tail frag- 
ment generated by cleavage of  the ectodomain (Pandiella and 
Massagu6,  1991a;  Bosenberg et al.,  1992).  Similar results 
were obtained with the other three mutant CHO clones (data 
not shown). These results indicated that the rates of TGF-a 
synthesis,  maturation and  transport to the cell  surface in 
these  mutants  are  indistinguishable  from  those  in  non- 
mutagenized CHO cells. 
PMA-inducible Cleavage in Wild-type 
and Mutant CHO Cells 
We next examined the cleavage of  proTGF-u in wild-type and 
mutant CHO cells in  response to PMA.  Since proTGF-a 
cleavage occurs at the cell surface (Bosenberg et al.,  1992, 
1993), we monitored the cleavage process by immunopre- 
cipitating cell surface proTGF-a as well as total proTGF-c~. 
Metabolically labeled cells were chased 20 min to allow 
transport of newly synthesized proTGF-a to the cell surface. 
The chase was then continued for up to 60 min with or with- 
out PMA  addition.  In  the  absence of PMA,  cell  surface 
Figure  2.  Biosynthesis and 
turnover  of TGF-ct in  wild- 
type and mutant CHO cells. 
Exponentially  growing cells 
were labeled with [35]cysteine 
for 10 min and chased in com- 
plete  medium  for  the  indi- 
cated  times. For determina- 
tions of  cell surface proTGF-c~, 
cells were incubated with HA 
antibody, lysed and  immune 
complexes  precipitated  with 
protein  A-agarose  as  de- 
scribed under  Materials  and 
Methods.  For  determination 
of  proTGF-tx  in the whole cell, 
cell lysates were precipitated 
with antiserum against the cy- 
toplasmic tail of proTGF-c~. 
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lease of soluble TGF-et into the medium (Fig. 3;  note that 
the indicated times started to count at the time of PMA addi- 
tion 20 min after initiation of the chase, hence the apparent 
differences in turnover rates with Fig. 2). 
In wild-type CHO cells proTGF-a was rapidly cleaved in 
response to PMA with release of soluble factor into the me- 
dium and accumulation of 15-kD tail in the cell (Fig. 3, bot- 
tom left), as previously described (Pandiella and Massagu6, 
1991a;  Bosenberg et al.,  1992).  In the mutants,  however, 
PMA  addition had  no effect on proTGF-tx cleavage.  Pro- 
TGF-ot turnover in these cells occurred without appearance 
of soluble factor in the medium or 15-kD tail in the cells, 
either in the presence or absence of PMA (Fig. 3). These re- 
sults confirmed the presence of a defect in proTGF-tx cleav- 
age. Similar results were obtained in the other three mutant 
lines (data not shown). 
B-APP Biosynthesis and Secretion in Wild-type 
and Mutant CHO Cells 
B-APP expression and processing via the amyloidogenic and 
non-amyloidogenic pathways are present in most tissues and 
cell types  (Tanzi et al.,  1989;  Weidemann et  al.,  1989). 
Metabolically  labeled  wild  type  CHO  cells  expressed  a 
B-APP immunoreactive species of 115 kD that was chased 
Figure 3. ProTGF-ct  cleavage in wild-type and mutant CHO cells. 
Exponentially. growing cells  were  pulsed with  [35S]cysteine for 
20 min, chased in complete medium for 20 min and then incubated 
with HA antibody. Cells were then further chased for the indicated 
times in the presence or absence of 1 ~M PMA. Immune complexes 
present in cell lysates and media were precipitated with protein 
A-agarose and analyzed by SDS-PAGE. Separately, lysates from 
PMA-treated cells were precipitated with antiserum against the cy- 
toplasmic tail of proTGF-c~. 
into a  form of 145 kD,  as  shown by immunoprecipitation 
with antibodies against the cytoplasmic domain of B-APP 
(Fig. 4). These forms correspond in size to immature and 
fully  glycosylated B-APE  respectively  (Buxbaum  et  al., 
1990). In the absence of PMA treatment, the rates of synthe- 
sis and turnover of B-APP in wild type and mutant CHO cells 
were similar (Fig. 4). Furthermore, the level of cell surface 
B-APP was also similar in both cell lines, as judged by immu- 
noprecipitation of surface-biotinylated B-APP (see Fig. 6). 
Processing of B-APP through the non-amyloidogenlc  path- 
way,  yielding the  secreted form APPs and  a  residual  tail 
fragment of 10 kD, can be stimulated with PMA (Buxbaum 
et al.,  1990).  This effect was observed in wild-type CHO 
cells but not in the mutants defective in proTGF-tx cleavage 
(Fig. 4). Only a low level of constitutive B-APP release, that 
was not affected by PMA, could be detected in these cells 
(Fig. 4). In the three clones that spontaneously reverted to 
wild-type phenotype with respect to TGF-tx cleavage, ~-APP 
cleavage was also restored (data not shown), providing fur- 
ther  evidence for a  genetic link between the  TGF-a and 
B-APP secretory mechanisms. 
Since various B-APP isoforms exist, and the identity of 
those endogenously expressed in CHO cells has not been es- 
tablished, we transfected wild-type CHO cells and two of the 
mutant clones with an expression vector encoding the human 
B-APP  °5  isoform  which  is  known  to  be  amyloidogenic 
(Sisodia et al., 1990). Immunoprecipitates of CHO cells sta- 
bly transfected with B-APP  695 showed additional B-APP im- 
munoreactive products of the size predicted for mature and 
immature  B-API  ~95  forms,  respectively  (Fig.  5,  arrows). 
The rates of maturation and turnover of transfected B-APP  ~ 
were indistinguishable from those of the endogenous B-APP 
in both wild-type and mutant CHO cells (data not shown). 
Addition of PMA  induced B-APP  695 cleavage in wild-type 
but not mutant CHO cells, as judged by disappearance of the 
mature B-APP  69~ form. These results confirmed a defect in 
cleavage of authentic B-APP in the mutants. Three randomly 
selected subclones from each of two mutant clones trans- 
fected  with  B-API  ~95  were  analyzed,  yielding  the  same 
results in all cases (data not shown). 
Resistance to Diverse Cleavage-activating Signals 
PMA activates TGF-c~ cleavage via PKC whereas calcium 
ionophores and serum factors activate this process in part by 
PKC-independent  mechanisms  (Pandiella  and  Massagu6, 
1991b).  Likewise,  ~APP  release  is  activated by calcium 
ionophores via a PKC-independent mechanism (Buxbaum et 
al.,  1994), and is activated also by serum factors (Fig. 6). 
In order to determine the effect of these agents on proTGF-ct 
and  B-APP cleavage,  we  monitored cell  surface pro-HA/ 
TGF-ct levels by labeling cells with HA antibody (as in Fig. 
2) and cell surface B-APP levels by cell surface biotinylation 
followed by two-step precipitation with antibodies against 
B-APP cytoplasmic tail and streptavidin-agarose beads. Like 
PMA, the calcium ionophore A23187 and fetal bovine se- 
rum promoted release of TGF-ct and B-APP in wild-type 
CHO cells but not in the mutant clones (Fig. 6, and data not 
shown).  These results argued that the signals conveyed by 
these various mechanisms converge on a component that lies 
downstream of different signaling pathways, and this compo- 
nent is essential for cleavage of different membrane proteins 
and is defective in the mutants. 
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wild-type  and  mutant  CHO 
cells.  Metabolically  labeled 
wild  type  and  mutant  CHO 
cells were chased  for the in- 
dicated  times  in  complete 
medium  with  or  without 
PMA. Cell lysates and media 
superrmtants  were  immuno- 
precipitated  with  antibodies 
against the cytoplasmic tail or 
the  extracellular  domain  of 
B-APE  respectively,  and  the 
immunoprecipitates  analyzed 
by SDS-PAGE. Bottom panels 
show the densitometric quan- 
tification of the labeled bands 
corresponding  to  soluble 
B-APP in the media samples. 
Figure 5.  Transfected B-APP  ~95 is resistant to cleavage in mutant 
CliO cells.  Wild-type and mutant CHO cells transfected with the 
human B-APP  ~95 were metabolically labeled and chased with com- 
plete medium for 45 min with or without PMA. Cell lysates were 
precipitated with antibodies against B-APP cytoplasmic tail,  and 
the immunoprecipitates analyzed by SDS-PAGE. 
Release of  Endogenous CHO Membrane Proteins 
by a Shared Secretory Mechanism 
The evidence that two structuraily and functionally different 
proteins,  proTGF-o~ and B-APE  share a  secretory system in 
CliO cells raised the possibility that this mechanism medi- 
ates the activated release of many other cell surface proteins. 
To test this possibility, wild-type and mutant CHO cells were 
metabolically  labeled,  then  cell  surface  biotinylated,  in- 
cubated for a brief period with or without PMA, and the ma- 
terial  released  into  the  medium  was  retrieved  with  strep- 
tavidin-agarose  beads.  In the absence of PMA,  there  was 
little release of cell surface proteins from either wild-type or 
mutant CliO cells (Fig.  7). In response to PMA,  wild-type 
CHO cells released cell surface proteins ranging from 30 to 
over  200  kD,  as  determined  by  electrophoresis  of  the 
streptavidin-bound radiolabeled material (Fig. 7). On the ha- 
The Journal of Cell Biology, Volume 128, 1995  438 Figure  6.  Different mechanisms  fail  to  activate pm'fGF-tx and 
~3-APP cleavage in mutant CHO cells. For analysis of cell surface 
proTGF-ct, cells were metabolically labeled for 20 rain, chased for 
20 min in complete medium, incubated with HA antibody and then 
incubated with 1 #M PMA, 1 #M A23187, 10% fetal bovine serum 
or no additions for 20 additional min. Cell lysates were precipitated 
with  protein  A-agarose  and  the  precipitates  analyzed by SDS- 
PAGE. For analysis of cell surface/3-APP, wild-type and mutant 
CHO cells transfected with human/3-APP ~95 were metabolically 
labeled and chased for 45 min,  incubated with sulfo-NHS-LC- 
Biotin, and then incubated for 15 min in complete medium with the 
indicated  agonists. Cell  lysates  were  subjected  to  a  two-step 
precipitation  with antibodies against /3-APP cytoplamic tail  and 
streptavidin-agarose beads, as described in Materials and Methods. 
The final precipitates were analyzed by SDS-PAGE. 
sis of recovered clam, the amount of  protein that bound to the 
streptavidin beads was only ~1% of  the total protein secreted 
into the media, and the radiolabeled protein profiles of both 
samples on SDS-PAGE gels were different (data not shown). 
This suggested that PMA specifically activated the release of 
Figure  7.  PMA-induced re- 
lease of  endogenous CHO cell 
surface  proteins.  Metaboli- 
cally labeled cells were incu- 
bated  with  sulfo-NHS-LC- 
Biotin  to  tag  cell  surface 
proteins,  and then  incubated 
with or without 1 #M PMA. 
Biotinylated proteins were re- 
covered from the media with 
streptavidin-agarose  beads. 
The  precipitates  were  ana- 
lyzed  on  6-16%  gradient 
polyacrylamide gels. 
cell surface proteins but not general exocytosis in CHO cells. 
Importantly, PMA did not activate the release of  any of  these 
proteins in the mutants (Fig. 7). These results indicate that 
the component affected by the mutations plays an essential 
role in a general mechanism for activated release of mem- 
brane protein ectodomains. 
Discussion 
Many membrane proteins involved in various aspects of cell 
communication and  regulation undergo cleavage with  re- 
lease of their ectodomains into the media. However, very lit- 
fie is known about the nature of the secretory mechanism in- 
volved in this process. One feature common to many of these 
cleavage processes is their inducibility by activators of PKC 
or calcium influx into the cytosol. Aside from this, no sim- 
ilarities can be found between the various proteins that un- 
dergo this process or, most remarkably, between the primary 
sequences at the cleavage sites (Wong et al.,  1989; Perez et 
al., 1990; Pandiella et al., 1992; Sahasrabudhe et al., 1992; 
Sisodia, 1992; Mfillberg et al., 1994). These properties raise 
the possibility that membrane protein ectodomain cleavage 
involves  a  large  number  of specific  proteolytic  systems. 
However, the genetic approach taken here to investigate this 
question provides support for the alternative possibility, that 
cleavage of diverse membrane protein ectodomains is medi- 
ated by a common mechanism whose regulatory and/or cata- 
lytic  components  might  be  relatively  few  and  of broad 
specificity. 
We selected CHO cell mutants that retained cell surface 
proTGF-c~ immunostaining  in  the presence of PMA.  The 
mutants isolated by this procedure appear free of defects in 
membrane protein  biosynthesis  and  dynamics,  as judged 
from the unaltered rates of proTGF-t~ maturation, transport 
to the cell surface and turnover. Nevertheless, these cells 
show  a  complete  resistance  to  PMA-induced  proTGF-oL 
cleavage. In the presence of PMA, proTGF-o~ remains at the 
cell surface and turns over without being converted into solu- 
ble factor, as it does in non stimulated wild-type CHO ceils. 
The evidence indicates that a  specific defect in proTGF-t~ 
cleavage is present in these cells. 
To investigate the generality of the affected process we fo- 
cused on/3-APP cleavage.  This choice was  made because 
/3-APP is unrelated to TGF-ot in expression pattern, cleavage 
site  and  probable  function,  and  also  because  defects  in 
/3-APP processing may be involved in the pathogenesis of 
Alzheimer's disease. Consistent with the widespread expres- 
sion of/3-APP, CHO cells express immunoreactive/3-APP 
polypeptides of 115 and 145 kD that presumably correspond 
to the immature and fully glycosylated forms, respectively 
(Weidemann et al.,  1989; Wang et al.,  1991). In agreement 
with previous reports, the release of  APPs into the cell media 
was stimulated upon cell treatment with PMA (Buxbaum et 
al.,  1990).  However, in  the cleavage-defective CHO  mu- 
tants, PMA does not accelerate APPs secretion, indicating 
that the component affected in these mutants is also neces- 
sary for regulated secretion of/3-APP. These mutants are also 
defective in the processing of a transfected human/3-APP iso- 
form  (13-App'95). As  with  TGF-ct,  the  rates  of synthesis, 
maturation and turnover of endogenous or transfected/3-APP 
are very similar in wild type and mutant CHO cells. More- 
over,  revertants  that  have  regained  the  ability  to  cleave 
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~-APP, further supporting the conclusion that the defective 
component is one involved in regulated cleavage of both pro- 
teins. 
An examination of endogenous cell surface proteins that 
undergo PMA-induced release provides further evidence for 
a general process that mediates the release of many different 
membrane proteins. In response to PMA, CHO cells release 
cell surface proteins that range in size from 30 to over 200 
kD.  Although the  identity of these  CHO proteins  is  not 
known, they are likely to represent a structurally and func- 
tionally diverse group. PMA-induced release of these pro- 
teins is defective in the mutants, indicating that these pro- 
teins share a common secretory process with proTGF-ct and 
/3-APP. 
ProTGF-ot and/3-APP ectodomain release can be activated 
by various independent mechanisms. Calcium ionophores 
act by a mechanism independent of PMA-responsive PKC 
isoforms whereas serum factors act by a calcium-indepen- 
dent mechanism (Pandiella and Massagut, 1991b). All these 
agents failed to stimulate cleavage of/3-APP or proTGF-ct in 
our mutants, indicating that the defective component func- 
tions downstream of the signals conveyed by these various 
activators. 
In conclusion, we have provided genetic evidence for a 
general mechanism that catalyzes regulated cleavage  and 
secretion of membrane protein ectodomains. The identity of 
the component(s) disrupted by these mutations remains to be 
determined. They could include a regulator of protease ac- 
tivity, a regulator of protease access to its substrates, or a 
shared protease. The presence of a regulatory element in this 
system can be inferred from the fact that the inducers of 
cleavage are activators of protein phosphorylation and yet, 
neither proTGF-c~ nor/3-APP are the relevant substrates since 
mutation of their potential phosphorylation sites does not 
affect cleavage  (Bosenberg et al., 1992;  Da Cruz e Silva et 
al., 1993; Hung and Selkoe, 1994). The cytoplasmic domain 
of proTGF-u  is  essential  for cleavage  (Bosenberg  et  al., 
1992) but the cytoplasmic domain of/3-APP is not (Sisodia, 
1992; DeStrooper et al., 1993; Haass et al., 1993; Hung and 
Selkoe,  1994),  arguing that the target of the present muta- 
tions is not one that recognizes this domain. ProTGF-u cleav- 
age occurs at the cell surface (Bosenberg et al.,  1993),  can 
be activated in permeabilized cells devoid of cytosol (Bosen- 
berg et al.,  1993),  and does not require membrane traffic 
(Bosenberg et al., 1993),  suggesting that regulated cleavage 
of these proteins  requires  relatively few membrane-asso- 
ciated components. Isolation of genes that complement the 
mutations described here should reveal the identity of these 
molecules. 
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